+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rapamycin-Eluting Coronary Stent System Market - Global Forecast 2025-2030- Product Image
Rapamycin-Eluting Coronary Stent System Market - Global Forecast 2025-2030- Product Image
Sale

Rapamycin-Eluting Coronary Stent System Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6146687
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Rapamycin-eluting coronary stent systems are redefining interventional cardiology by leveraging advanced materials and smarter drug delivery to improve patient outcomes. This report outlines the transformative forces shaping this dynamic market, equipping senior decision-makers with actionable intelligence and strategic recommendations for sustained growth and competitiveness.

Market Snapshot: Rapamycin-Eluting Coronary Stent Systems

The rapamycin-eluting coronary stent system market is experiencing robust expansion, propelled by technological innovation and evolving healthcare environments. With rapid growth in advanced economies and emerging markets alike, the sector is characterized by increased adoption rates, deepening clinical sophistication, and ongoing investment in research and development. Variations in reimbursement policies, regulatory frameworks, and patient demographics further contribute to the dynamic landscape, positioning the market for continued advancement.

Scope & Segmentation

This executive analysis provides comprehensive coverage of the rapamycin-eluting coronary stent system market through multiple critical dimensions. Market insights span technology, clinical application, regional distribution, and patient segmentation.

  • Clinical Indications: Acute myocardial infarction, chronic total occlusion, in-stent restenosis, and stable angina.
  • Deployment Mechanisms: Balloon expandable and self expandable device types.
  • End Users: Ambulatory surgical centers, hospitals, and specialty clinics.
  • Coating Materials: Polymer based (polyethylene glycol, polylactic acid, polyvinyl pyrrolidone) and polymer free strategies.
  • Stent Diameters: Greater than 3.5 millimeters, less than 3 millimeters, and 3 to 3.5 millimeters.
  • Stent Lengths: Fifteen to thirty millimeters, less than fifteen millimeters, and greater than thirty millimeters.
  • Access Routes: Transbrachial, transfemoral, and transradial procedures.
  • Patient Demographics: Segmentation by gender (male, female) and age group (adult 18–65 years, geriatric above 65 years).
  • Regional Markets: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—plus Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and others); Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia, and more).
  • Key Market Participants: Terumo Corporation, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Beijing Lepu Medical Technology Co., Ltd., JW Medical Systems Co., Ltd., Meril Life Sciences Pvt. Ltd., B. Braun Melsungen AG, Medinol Ltd., Biosensors International Group, Ltd.

Key Takeaways for Senior Decision-Makers

  • Recent breakthroughs in material science and imaging technologies continue to drive better clinical outcomes while solidifying procedural predictability and minimizing adverse events.
  • The move toward ultra-thin strut profiles and advanced biodegradable polymers reflects an industry-wide focus on tailoring devices to complex lesion characteristics and anatomical diversity.
  • Major regions, including the Americas, EMEA, and Asia-Pacific, display distinct approaches to healthcare delivery, regulatory compliance, and adoption rates—compelling stakeholders to pursue market-specific strategies.
  • With evolving reimbursement models and enhanced post-market surveillance, compliance requirements are intensifying, requiring manufacturers to demonstrate robust safety and efficacy.
  • Strategic partnerships between multinational leaders and local manufacturers, as well as collaboration with key opinion leaders, are accelerating product innovation and clinical adoption.

Tariff Impact: 2025 U.S. Regulatory Reforms

Upcoming tariff reforms in the United States are reshaping the global supply chain for rapamycin-eluting coronary stent systems. Increased import duties on device components are driving a shift toward domestic manufacturing and dual-sourcing strategies. Manufacturers and distributors are adapting procurement and inventory approaches to contain costs, while maintaining emphasis on product quality and supply chain resilience. These tariff-driven changes present an opportunity to strengthen domestic capability and mitigate future risk exposure.

Methodology & Data Sources

This report employs a rigorous, multi-source research methodology, combining in-depth interviews with interventional cardiologists, device engineers, and procurement specialists, alongside structured surveys for quantitative analysis. Secondary research includes review of peer-reviewed literature, regulatory filings, clinical trial registries, and industry benchmarks. Robust statistical modeling and data triangulation ensure reliability and comprehensive insight.

Why This Report Matters

  • Enables executive-level decision-making with comprehensive insights into evolving technologies, regulations, and commercial trends.
  • Supports the development of resilient, adaptive strategies in response to complex tariff and reimbursement changes.
  • Equips commercial leaders to identify underpenetrated segments and unlock new growth opportunities worldwide.

Conclusion

The rapamycin-eluting coronary stent system market is in a period of dynamic transformation, shaped by innovation, regulation, and regional variations. Strategic insight and adaptive planning will be essential for market success amid increasing complexity.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of biodegradable polymer coatings to reduce late stent thrombosis risk
5.2. Integration of nanoparticle-based rapamycin carriers for precise drug release kinetics
5.3. Development of personalized stent sizing using AI-driven coronary imaging analysis
5.4. Regulatory shifts accelerating market entry of next-generation poly-L-lactic acid stents with rapamycin
5.5. Growth in emerging economies driven by government reimbursement reforms for drug-eluting stents
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Rapamycin-Eluting Coronary Stent System Market, by Clinical Indication
8.1. Introduction
8.2. Acute Myocardial Infarction
8.3. Chronic Total Occlusion
8.4. In-Stent Restenosis
8.5. Stable Angina
9. Rapamycin-Eluting Coronary Stent System Market, by Deployment Mechanism
9.1. Introduction
9.2. Balloon Expandable
9.3. Self Expandable
10. Rapamycin-Eluting Coronary Stent System Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Rapamycin-Eluting Coronary Stent System Market, by Coating Material
11.1. Introduction
11.2. Polymer Based
11.2.1. Polyethylene Glycol
11.2.2. Polylactic Acid
11.2.3. Polyvinyl Pyrrolidone
11.3. Polymer Free
12. Rapamycin-Eluting Coronary Stent System Market, by Stent Diameter
12.1. Introduction
12.2. Greater Than Three Point Five Millimeters
12.3. Less Than Three Millimeters
12.4. Three To Three Point Five Millimeters
13. Rapamycin-Eluting Coronary Stent System Market, by Stent Length
13.1. Introduction
13.2. Fifteen To Thirty Millimeters
13.3. Greater Than Thirty Millimeters
13.4. Less Than Fifteen Millimeters
14. Rapamycin-Eluting Coronary Stent System Market, by Access Route
14.1. Introduction
14.2. Transbrachial
14.3. Transfemoral
14.4. Transradial
15. Rapamycin-Eluting Coronary Stent System Market, by Patient Gender
15.1. Introduction
15.2. Female
15.3. Male
16. Rapamycin-Eluting Coronary Stent System Market, by Patient Age Group
16.1. Introduction
16.2. Adult Eighteen To Sixty Five Years
16.3. Geriatric Above Sixty Five Years
17. Americas Rapamycin-Eluting Coronary Stent System Market
17.1. Introduction
17.2. United States
17.3. Canada
17.4. Mexico
17.5. Brazil
17.6. Argentina
18. Europe, Middle East & Africa Rapamycin-Eluting Coronary Stent System Market
18.1. Introduction
18.2. United Kingdom
18.3. Germany
18.4. France
18.5. Russia
18.6. Italy
18.7. Spain
18.8. United Arab Emirates
18.9. Saudi Arabia
18.10. South Africa
18.11. Denmark
18.12. Netherlands
18.13. Qatar
18.14. Finland
18.15. Sweden
18.16. Nigeria
18.17. Egypt
18.18. Turkey
18.19. Israel
18.20. Norway
18.21. Poland
18.22. Switzerland
19. Asia-Pacific Rapamycin-Eluting Coronary Stent System Market
19.1. Introduction
19.2. China
19.3. India
19.4. Japan
19.5. Australia
19.6. South Korea
19.7. Indonesia
19.8. Thailand
19.9. Philippines
19.10. Malaysia
19.11. Singapore
19.12. Vietnam
19.13. Taiwan
20. Competitive Landscape
20.1. Market Share Analysis, 2024
20.2. FPNV Positioning Matrix, 2024
20.3. Competitive Analysis
20.3.1. Terumo Corporation
20.3.2. Biotronik SE & Co. KG
20.3.3. MicroPort Scientific Corporation
20.3.4. Beijing Lepu Medical Technology Co., Ltd.
20.3.5. JW Medical Systems Co., Ltd.
20.3.6. Meril Life Sciences Pvt. Ltd.
20.3.7. B. Braun Melsungen AG
20.3.8. Medinol Ltd.
20.3.9. Biosensors International Group, Ltd.
21. ResearchAI
22. ResearchStatistics
23. ResearchContacts
24. ResearchArticles
25. Appendix
List of Figures
FIGURE 1. RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2024 VS 2030 (%)
FIGURE 20. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 22. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ASIA-PACIFIC RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. ASIA-PACIFIC RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 33. RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET: RESEARCHAI
FIGURE 34. RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET: RESEARCHSTATISTICS
FIGURE 35. RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET: RESEARCHCONTACTS
FIGURE 36. RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY IN-STENT RESTENOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY IN-STENT RESTENOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYETHYLENE GLYCOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYETHYLENE GLYCOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYVINYL PYRROLIDONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYVINYL PYRROLIDONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER FREE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER FREE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN THREE POINT FIVE MILLIMETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN THREE POINT FIVE MILLIMETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN THREE MILLIMETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN THREE MILLIMETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY THREE TO THREE POINT FIVE MILLIMETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY THREE TO THREE POINT FIVE MILLIMETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY FIFTEEN TO THIRTY MILLIMETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY FIFTEEN TO THIRTY MILLIMETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN THIRTY MILLIMETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN THIRTY MILLIMETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN FIFTEEN MILLIMETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN FIFTEEN MILLIMETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY TRANSBRACHIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY TRANSBRACHIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY TRANSRADIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY TRANSRADIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY FEMALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ADULT EIGHTEEN TO SIXTY FIVE YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ADULT EIGHTEEN TO SIXTY FIVE YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GERIATRIC ABOVE SIXTY FIVE YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GERIATRIC ABOVE SIXTY FIVE YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 128. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 129. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2024 (USD MILLION)
TABLE 130. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2025-2030 (USD MILLION)
TABLE 131. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2018-2024 (USD MILLION)
TABLE 134. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2025-2030 (USD MILLION)
TABLE 135. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2018-2024 (USD MILLION)
TABLE 136. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2025-2030 (USD MILLION)
TABLE 137. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2018-2024 (USD MILLION)
TABLE 138. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2025-2030 (USD MILLION)
TABLE 139. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2018-2024 (USD MILLION)
TABLE 140. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2025-2030 (USD MILLION)
TABLE 141. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2018-2024 (USD MILLION)
TABLE 142. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2025-2030 (USD MILLION)
TABLE 143. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 144. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 145. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 146. CANADA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 147. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 148. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 149. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2024 (USD MILLION)
TABLE 150. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2025-2030 (USD MILLION)
TABLE 151. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2018-2024 (USD MILLION)
TABLE 154. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2025-2030 (USD MILLION)
TABLE 155. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2018-2024 (USD MILLION)
TABLE 156. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2025-2030 (USD MILLION)
TABLE 157. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2018-2024 (USD MILLION)
TABLE 158. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2025-2030 (USD MILLION)
TABLE 159. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2018-2024 (USD MILLION)
TABLE 160. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2025-2030 (USD MILLION)
TABLE 161. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 164. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 165. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 166. MEXICO RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 249. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 250. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 251. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2024 (USD MILLION)
TABLE 252. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2025-2030 (USD MILLION)
TABLE 253. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2018-2024 (USD MILLION)
TABLE 256. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COATING MATERIAL, 2025-2030 (USD MILLION)
TABLE 257. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2018-2024 (USD MILLION)
TABLE 258. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER BASED, 2025-2030 (USD MILLION)
TABLE 259. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2018-2024 (USD MILLION)
TABLE 260. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT DIAMETER, 2025-2030 (USD MILLION)
TABLE 261. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2018-2024 (USD MILLION)
TABLE 262. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STENT LENGTH, 2025-2030 (USD MILLION)
TABLE 263. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2018-2024 (USD MILLION)
TABLE 264. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACCESS ROUTE, 2025-2030 (USD MILLION)
TABLE 265. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2018-2024 (USD MILLION)
TABLE 266. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT GENDER, 2025-2030 (USD MILLION)
TABLE 267. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 268. GERMANY RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 269. FRANCE RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 270. FRANCE RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 271. FRANCE RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2024 (USD MILLION)
TABLE 272. FRANCE RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT MECHANISM, 2025-2030 (USD MILLION)
TABLE 273. FRANCE RAPAMYCIN-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Rapamycin-Eluting Coronary Stent System market report include:
  • Terumo Corporation
  • Biotronik SE & Co. KG
  • MicroPort Scientific Corporation
  • Beijing Lepu Medical Technology Co., Ltd.
  • JW Medical Systems Co., Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • B. Braun Melsungen AG
  • Medinol Ltd.
  • Biosensors International Group, Ltd.

Related Topics

Related Reports

Coronary Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Coronary Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market - Global Forecast 2025-2030 - Product Image

Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Bioabsorbable Eluting Coronary Stent System Market - Global Forecast 2025-2030 - Product Image

Bioabsorbable Eluting Coronary Stent System Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Coronary Stents Market Report 2025 - Product Image

Coronary Stents Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Coronary Stents - Global Strategic Business Report - Product Image

Coronary Stents - Global Strategic Business Report

  • Report
  • 342 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.